Latest research progress on tumor-infiltrating lymphocytes in HER2-positive and triple-negative breast cancer

Triple-negative breast cancer (TNBC) and human epidermal growth factor receptor-2 (HER2)-positive breast cancer are the most aggressive subtypes of breast cancer with higher recurrent rates, distant metastasis rates and poor prognosis. There are increasing evidence suggesting that high level of tumo...

Descripció completa

Dades bibliogràfiques

Autor principal:	JI Peng
Format:	Artigo
Idioma:	Inglês
Publicat:	Editorial Office of China Oncology 2018-01-01
Col·lecció:	Zhongguo aizheng zazhi
Matèries:	Tumor-infiltrating lymphocytes Triple-negative breast cancer HER2-positive breast cancer Immunotherapy
Accés en línia:	http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2018.12.008
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!